|
顺-3-氟-4-羟基哌啶-1-羧酸叔丁酯
|
T178514-250mg
|
≥97% |
955028-88-3 |
250mg
|
¥ 54.9
|
现货 |
|
0 |
阿拉丁 |
|
4-(三氟甲基)哌啶-4-醇
|
T176304-5g
|
≥97% |
373603-69-1 |
5g
|
¥ 1699.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-(三氟甲基)哌啶-4-醇
|
T176304-250mg
|
≥97% |
373603-69-1 |
250mg
|
¥ 114.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-(三氟甲基)哌啶-4-醇
|
T176304-100mg
|
≥97% |
373603-69-1 |
100mg
|
¥ 52.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,8-二氮杂螺[4.5]癸-2-羧酸叔丁酯
|
T176168-5g
|
≥97% |
336191-17-4 |
5g
|
¥ 1052.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,2,4,4-四甲基-3-戊酮亚胺
|
T162311-250mg
|
≥96% |
29097-52-7 |
250mg
|
¥ 159.9
|
现货 |
|
0 |
阿拉丁 |
|
三己胺
|
T162178-1ml
|
≥95%(GC) |
102-86-3 |
1ml
|
¥ 35.9
|
现货 |
|
0 |
阿拉丁 |
|
1,2,3-三苯基胍
|
T162143-1g
|
≥97% |
101-01-9 |
1g
|
¥ 139.9
|
现货 |
|
0 |
阿拉丁 |
|
1,3,5-三(叔丁硫基)苯
|
T162115-5g
|
≥98% |
260968-03-4 |
5g
|
¥ 1299.9
|
现货 |
|
0 |
阿拉丁 |
|
十四烷基环己烷
|
T161710-200mg
|
≥95% |
1795-18-2 |
200mg
|
¥ 95.9
|
现货 |
|
0 |
阿拉丁 |
|
2,2,2-三溴乙醇
|
T161626-1g
|
≥98%(GC) |
75-80-9 |
1g
|
¥ 77.9
|
现货 |
|
0 |
阿拉丁 |
|
3-(2-噻吩基)吡啶
|
T135355-500mg
|
≥95% |
21298-53-3 |
500mg
|
¥ 226.9
|
现货 |
|
0 |
阿拉丁 |
|
3-(2-噻吩基)吡啶
|
T135355-100mg
|
≥95% |
21298-53-3 |
100mg
|
¥ 69.9
|
现货 |
|
0 |
阿拉丁 |
|
四甲基乙二胺(TEMED)
|
T105496-500ml
|
用于电泳, ≥99% |
110-18-9 |
500ml
|
¥ 599.9
|
现货 |
|
0 |
阿拉丁 |
|
丙烯酸四氢呋喃酯
|
T102693-25g
|
≥98%, 含500ppmMEHQ稳定剂 |
2399-48-6 |
25g
|
¥ 74.9
|
现货 |
|
0 |
阿拉丁 |
|
丙烯酸四氢呋喃酯
|
T102693-100g
|
≥98%, 含500ppmMEHQ稳定剂 |
2399-48-6 |
100g
|
¥ 239.9
|
现货 |
|
0 |
阿拉丁 |
|
茶螺烷
|
T102650-250mg
|
工业级, ≥90%, mixture of isomers |
36431-72-8 |
250mg
|
¥ 29.9
|
现货 |
|
0 |
阿拉丁 |
|
茶螺烷
|
T102650-1g
|
工业级, ≥90%, mixture of isomers |
36431-72-8 |
1g
|
¥ 79.9
|
现货 |
|
0 |
阿拉丁 |
|
(3S)-3-[4-[(5-溴-2-氯苯基)甲基]苯氧基]四氢呋喃
|
S590711-5g
|
≥97% |
915095-89-5 |
5g
|
¥ 169.9
|
现货 |
|
0 |
阿拉丁 |
|
(3S)-3-[4-[(5-溴-2-氯苯基)甲基]苯氧基]四氢呋喃
|
S590711-25g
|
≥97% |
915095-89-5 |
25g
|
¥ 647.9
|
现货 |
|
0 |
阿拉丁 |
|
Erlizumab (anti-CD18)
|
Ab183450-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
211323-03-4 |
1mg
|
¥ 3319.9
|
现货 |
|
0 |
阿拉丁 |
|
Visugromab (anti-GDF15)
|
Ab182987-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
2556646-63-8 |
1mg
|
¥ 2859.9
|
现货 |
|
0 |
阿拉丁 |
|
Uliledlimab (anti-CD73)
|
Ab182937-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
2378407-27-1 |
1mg
|
¥ 2899.9
|
现货 |
|
0 |
阿拉丁 |
|
Levilimab (anti-IL-6Ra)
|
Ab182913-1mg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
2035008-70-7 |
1mg
|
¥ 3319.9
|
现货 |
|
0 |
阿拉丁 |